Abstract
In recent studies, aminoguanidine (AG), an inhibitor of advanced glycation endproducts, has been identified as a prominent agent that can prevent the age-related aortic stiffening and cardiac hypertrophy. The aim of this study was to determine whether AG had effects on the left ventricular (LV)-arterial coupling in aged Fisher 344 rats in terms of the ventricular and arterial chamber properties. Normotensive rats were treated from 18 to 24 months with AG (1 g l(-1) in drinking water) and compared with a control group. LV pressure and ascending aortic flow signals were recorded to construct the ventricular and arterial end-systolic pressure-stroke volume relationships to calculate LV end-systolic elastance (Ees) and effective arterial volume elastance (Ea), respectively. The optimal afterload (Qload) determined by the ratio of Ea to Ees was used to measure the efficiency of mechanical energy transferred from the left ventricle to the arterial system. In comparison with the 6-month-old rats, the 24-month-old animals had decreased Ees, at 567.4 +/- 26.7 vs 639.0 +/- 20.7 mmHg ml(-1), decreased Ea, at 411.5 +/- 18.6 vs 577.9 +/- 15.7 mmHg ml(-1), and decreased Q(load), at 0.9428 +/- 0.0024 vs 0.9962 +/- 0.0014. Treatment with AG fo...Continue Reading
References
Nov 1, 1978·Circulation Research·K Sagawa
Jan 1, 1992·Advances in Pharmacology·R Bucala, A Cerami
May 11, 1992·Circulation Research·T KubotaA Takeshita
Jan 1, 1991·Circulation·M TakeuchiH Fukuzaki
May 19, 1988·The New England Journal of Medicine·M BrownleeH Vlassara
Jun 27, 1986·Science·M BrownleeA Cerami
Apr 1, 1985·Circulation Research·K SunagawaK Sagawa
Mar 1, 1973·Circulation Research·H SugaA A Shoukas
Jan 1, 1984·Annals of Biomedical Engineering·K SunagawaW L Maughan
Jun 1, 1981·Circulation·K Sagawa
Jun 1, 1980·IEEE Transactions on Bio-medical Engineering·K SunagawaY Nose
Apr 1, 1993·Physiological Reviews·E G Lakatta
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y M LiH Vlassara
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·B CormanB I Levy
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·B H WolffenbuttelB I Lévy
Feb 10, 1999·Experimental Gerontology·S M McCannV Rettorri
Mar 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·M AsifT J Regan
Sep 20, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·K C ChangY Z Tseng
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·P V VaitkeviciusE G Lakatta
Apr 28, 2001·British Journal of Pharmacology·K C ChangY Z Tseng
Sep 26, 2001·Circulation·D A KassE G Lakatta
Oct 20, 2001·Hypertension·C CantiniI Lartaud-Idjouadiene
Sep 12, 2003·British Journal of Pharmacology·Kuo-Chu ChangYung-Zu Tseng
Citations
May 10, 2012·Experimental Gerontology·Jochen SteppanDan E Berkowitz
Mar 18, 2005·Aging Cell·Shi-Yan LiJun Ren
Jul 9, 2004·British Journal of Pharmacology·Doron Aronson
Nov 21, 2007·European Journal of Heart Failure·Jasper W L HartogDirk J van Veldhuisen
Jan 12, 2019·PloS One·Bianca de Moraes FracassoMichael Andrades
Aug 18, 2006·ChemMedChem·Giancarlo AldiniMarina Carini
Oct 18, 2006·Medicinal Research Reviews·Giancarlo AldiniMarina Carini
May 19, 2017·Clinical Science·Marie FrimatEric Boulanger
Aug 12, 2016·Turkish Journal of Medical Sciences·Changjuan HaoZhaojun Li